Anti-neutrophil cytoplasmic antibodies (ANCA) Anti-neutrophil cytoplasmic antibodies (ANCA) are key biomarkers in the diagnosis of ANCA-associated vasculitis (AAV), a group of rare but potentially life-threatening autoimmune diseases. They can also have clinical and diagnostic value in certain non-AAV conditions. Early and accurate detection of ANCA is critical for initiating treatment promptly and improving long-term outcomes. […]

We are pleased to share the results of a newly published peer-reviewed study in Scientific Reports that demonstrates the diagnostic performance of the CytoBead® ANA 2 assay1. In clinical diagnostics, the detection of antinuclear antibodies (ANA) is crucial in identifying systemic autoimmune rheumatic diseases (SARDs). Traditional diagnostics use a two-step process. First, ANA screening by […]

Type 1 diabetes management has long relied on insulin injections, carbohydrate counting, and vigilant blood sugar monitoring. But how will the landscape in the near future look like? According to prominent German pediatric endocrinologist Felix Reschke (Kinder- und Jugendkrankenhaus in Hannover), the next five years could redefine treatment strategies entirely – he said in an […]

June is recognized as Scleroderma Awareness Month to honor those affected by the disease. The month ends with World Scleroderma Day on June 29. This date commemorates Swiss painter Paul Klee, who died of systemic sclerosis in 19401. Scleroderma, or systemic sclerosis, is a rare autoimmune disease. It causes hardening and tightening of the skin […]

Celiac disease (CD) diagnosis has advanced significantly over the past decade. Global guidelines now emphasize a combination of serology, genetics, and histology. While regional approaches differ, all aim for accurate diagnosis with minimal invasiveness. Core serological markers include antibodies against tissue transglutaminase (tTG), deamidated gliadin peptide (DG), and endomysial antibodies (EmA), assessed in both IgA […]

Antiphospholipid Syndrome (APS) is a major risk factor for pregnancy complications, yet diagnosing it remains challenging. Recent advancements in APS diagnostics provide deeper insights into its role in recurrent pregnancy loss and preeclampsia. Cutting-edge biomarker research and refined testing methods are improving accuracy, helping clinicians better identify at-risk patients and tailor treatment strategies. Discover the latest developments in APS diagnostics and their impact on maternal and fetal health.

Stay Ahead in Diagnostics and Subscribe to Our Medipan & GA Generic Assays‘ Newsletter In the fast-evolving field of diagnostics, staying informed is key. With the Medipan & GA Generic Assays newsletter, you gain exclusive access to our latest advancements, research insights, and innovative solutions in autoimmune and infectious disease diagnostics.  Why Subscribe?  As a […]

The International Consensus on ANA Patterns (ICAP) has taken another significant step in the continuous advancement to promote harmonization and understanding in antinuclear antibodies (ANA) of the HEp-2 IFA. As previously anticipated, in the ongoing update of the ANA pattern classification, two newly identified patterns, AC-30 and AC-31, have been incorporated into the ICAP nomenclature […]

A recent outbreak of Guillain-Barré Syndrome (GBS) in Pune, India, has seen approximately 160 reported cases since early January. The outbreak has been linked to Campylobacter jejuni, a foodborne pathogen and one of the leading causes of GBS worldwide1. Understanding Guillain-Barré Syndrome and Its Triggers GBS is a rare autoimmune disease where the immune system […]

Extended Shelf Life for Our RIA Kits We are pleased to announce that our optimized production processes now ensure you receive RIA Kits SELco® TSH Rapid, SELco® Tg 1 Step, and SELco® Calcitonin with an extended shelf life of additional two weeks. Thanks to these improvements, we now complete the production process two weeks earlier, […]